Navigation Links
University of Maryland School of Medicine Holds First "Festival of Science" to Launch New Program for Accelerating Innovation and Discovery in Medicine
Date:11/22/2013

BALTIMORE, Nov. 22, 2013 /PRNewswire-USNewswire/ -- The University of Maryland School of Medicine (SOM) is today launching a major initiative, Accelerating Innovation and Discovery in Medicine (ACCEL-Med), to increase the pace and scope of clinical and basic sciences research that will dramatically impact and improve human health and wellbeing. The initiative will be kicked off with a  full-day symposium, the SOM Festival of Science, at the UM campus in Baltimore. Francis Collins, MD, PhD, Director of the National Institutes of Health, will give the inaugural keynote address. Additional speakers, representing the School of Medicine's Institute for Genome Sciences, Department of Pharmacology and Department of Surgery, will reflect a sampling of SOM's robust basic, translational and clinical research portfolio.

Dr. Collins will specifically address the current environment for biomedical research, including the need for advancing discovery through technology and translational sciences, the importance of continuous innovation and the economic benefits of medical research.

A cornerstone of the ACCEL-Med Initiative is an external Scientific Advisory Council (SAC), which consists of five internationally acclaimed biomedical researchers and physician-scientists, who will provide critical advice on SOM's research, programs and plans, as well as guidance and support for junior faculty presenters. Members of the first Council include Rita Colwell, PhD, former Director of the National Science Foundation; Carol Greider, PhD, co-recipient of the 2009 Nobel Prize for Physiology or Medicine; Philip Needleman, PhD, former President of Searle R&D and an SOM alum; Ralph Snyderman, MD, Chancellor Emeritus at Duke University, who will serve as this year's SAC Chair; and Elias Zerhouni, MD, President of Global R&D at Sanofi and former NIH Director.

"We are delighted to welcome Dr. Collins to our campus and that a dais of preeminent scientists has agreed to be a part of the Scientific Advisory Council for the ACCEL-Med Initiative," said Dean E. Albert E. Reece, MD, PhD, MBA, Vice President for Medical Affairs at the University of Maryland and the John Z. and Akiko K. Bowers Distinguished Professor and Dean of the University of Maryland School of Medicine. "When I invited these distinguished scientists to join us for this important project, not only were they eager to help, several of them mentioned how impressed they were with the dynamic progress the School of Medicine has made over the past several years. The School of Medicine has persevered in the face of many socio-political obstacles, and taken a bold, strategic and selective approach to building its research mission."

About the University of Maryland School of Medicine

Established in 1807, the University of Maryland School of Medicine was the first public medical school in the United States, and the first to institute a residency-training program. The School of Medicine was the founding school of the University of Maryland and today is an integral part of the 11-campus University System of Maryland. On the University of Maryland's Baltimore campus, the School of Medicine serves as the anchor for a large academic health center which aims to provide the best medical education, conduct the most innovative biomedical research and provide the best patient care and community service to Maryland and beyond. www.medschool.umaryland.edu.

NOTE TO EDITORS:  Backgrounder available at: http://somvweb.som.umaryland.edu/absolutenm/templates/?a=2567&z=28


'/>"/>
SOURCE University of Maryland School of Medicine
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. University Health Shreveport Unveils Xenex Germ-Zapping Robot to Enhance Patient Safety
2. Genera Energy, University of Tennessee Complete $5 Million Biofuels Grant
3. International Collaboration Puts the Future of Healthcare IT on Display at the University City Science Center
4. Hamilton Scientific Products Installed at Wisconsin Energy Institute & Consolidated Forensic Lab, University of Wisconsin
5. Harvard University: Big Pharma is Corrupted; CBCD Sees Connection between Corruption & Productivity Crisis in R&D
6. Hun School Bio Students Conduct Original Molecular Research in Conjunction with Rutgers University
7. Student at Cleveland’s University School Conducts Research on the Role of Hair Cells in Hearing
8. Mainz University receives approval for an Alexander von Humboldt Professorship in Physics
9. BioNano Genomics Announces The Purchase Of The Irys System By The Chinese Academy Of Sciences And Tel Aviv University
10. McCord Research Hires Former University of Iowa Researcher
11. Licensing deal marks coming of age for University of Washington, University of Alabama-Birmingham
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017  In Atlanta, it seems everyone ... and culture intertwine to create an expressive and dynamic community ... this energy and contribute to it. With ... Hair Fairies seeks to carry on that tradition with ... Atlanta salon is the newest of 13 ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... de novo clearance to begin marketing the SPEAC® System, the Brain Sentinel® Seizure ... at home or in healthcare facilities during periods of rest. A lightweight, non-invasive ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... (such as insulin, cortisol, CRP, adiponectin, uric acid, and/or other biomarkers or SNPs ... Insulin Assay from Salimetrics’ SalivaLab , the relationship between insulin and other ...
(Date:2/23/2017)... DIEGO , Feb. 23, 2017 ... research tools, announced the acquisition of GenWay Biotech ... a comprehensive service and product offering for both ... acquisition will facilitate growth and enhance capabilities for ... antibodies, and ELISA assays will nicely complement ASB,s ...
Breaking Biology Technology:
(Date:2/3/2017)... 2017  Texas Biomedical Research Institute announced that its Board ... as the Institute,s new President and CEO. Dr. Schlesinger ... 2017. He is currently the Chair of the Department of ... Microbial Interface Biology at Ohio State University. "We ... and CEO of Texas Biomed," said Dr. James O. ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
(Date:2/2/2017)... TOKYO , Feb. 1, 2017  Central ... innovative and meaningful advances worldwide, The Japan Prize ... Japan Prize, who have pushed the envelope in ... Information and Communication. Three scientists are being recognized ... outstanding achievements that not only contribute to the ...
Breaking Biology News(10 mins):